Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team.

Lancet. 2009 Jun 20;373(9681):2125-35. doi: 10.1016/S0140-6736(09)60953-3. Epub 2009 Jun 6.

PMID:
19501900
2.

[Biotransformation of 1,2- 3 H-testosterone by HeLa cells].

Schaffstein W, Träger L.

Naturwissenschaften. 1972 May;59(5):215-6. German. No abstract available.

PMID:
5049194

Supplemental Content

Loading ...
Support Center